Small molecule · Inhibitor of 1,3-beta-glucan synthase · developed by Merck
ApprovedFDA, Jan 2001
1Registered trials
What is Caspofungin?
Caspofungin is an echinocandin antifungal lipopeptide that inhibits 1,3-beta-glucan synthase, reducing synthesis of beta(1,3)-D-glucan, an essential component of the fungal cell wall. It is active against Aspergillus and Candida species. It is used in the treatment of candidiasis and invasive fungal infections, including candidemia.
Summary written with AI from the sources listed at the end of this page.
Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z
This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.